NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/24/2024
Back to search
Official data from USPTO
TRANSGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRANSGENE
ST13
US500000085917725Class
1, 5, 42
Filing
85917725
Registration
4531052
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/24/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
04/29/2013
Registration date
05/13/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/24/2024
Last transaction
07/24/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Illkirch-graffenstaden, FR
Examiner
FATHY, DOMINIC
Holders and representatives
Holders
Transgene, S.A.
Representatives
Pina Campagna Carter, DeLuca, & Farrell, LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in research in the field of chemistry bacteriologyvirologyimmunologymolecular biologygenetic engineeringgene therapy and human and veterinary medicinechemical reagentslytic reagentsbacteriostatic reagentsfungicidal reagentsenzyme reagentsrinsing reagents and cleaning reagents all for use with hematologycytologicalparticulatevirological and chemical analytical automated and semiautomated study and analysis instrumentsmachines and systems used in diagnosticindustrialbiologicalcytology laboratories all for scientific or research use; monoclonal antibodies and antigens for diagnosticscientificresearch use; reagentsdiluents and buffers as packaged in ready-to-use dispensing packages for scientific or research use; cell markers used as reagents for diagnosticscientificresearch use; dyes and stains for microscopic specimen slides and flow cytometry used in diagnostic or scientific research; microspheresfluoroscopes and monodispersed particles for use as standardscalibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biologicalindustrialacademic fields for scientific or research use; whole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnosticscientific or research use; diluentsstandardsstabilizersbuffersreference control compositionsimmersion oilsheath fluids and wetting fluids for scientific and research use; diagnostic laboratory reagents for hemoglobin testing for scientific and research use; reagents for hemoglobin testing for scientific and research use; reagents for use with automatic chemical analysis instruments in biologicalchemicalindustrial and clinical laboratories for scientific or research use; and cell markers for diagnostic and research use
Class 5
Pharmaceutical preparations for use in treatment of cancercentral nervous system diseasesmultiple sclerosisautoimmune diseases and hypersensitivitiesinfectious diseases and hematological conditions
Class 42
Research and scientific studies in the fields of chemistrybacteriologygeneticshuman and veterinary medicine
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/24/2024
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
07/24/2024
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
07/24/2024
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
07/24/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/24/2024
PCBM
PETITION TO DIRECTOR WITHDRAWN
07/15/2024
APET
ASSIGNED TO PETITION STAFF
06/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
05/01/2024
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
05/01/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
04/29/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/13/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/30/2019
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
10/30/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/30/2019
ES8R
TEAS SECTION 8 RECEIVED
10/10/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/13/2019
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/13/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2014
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/01/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2014
GNRT
NON-FINAL ACTION E-MAILED
03/13/2014
CNRT
NON-FINAL ACTION WRITTEN
03/13/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2014
ALIE
ASSIGNED TO LIE
02/13/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/20/2013
GNRT
NON-FINAL ACTION E-MAILED
08/20/2013
CNRT
NON-FINAL ACTION WRITTEN
08/20/2013
DOCK
ASSIGNED TO EXAMINER
08/15/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
05/07/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2013
NWAP
NEW APPLICATION ENTERED
05/02/2013
Continuous trademark protection
Get notified about every new filing that threatens TRANSGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.